13F-HR filed by Abingworth LLP
Abingworth LLP filed this 13F-HR for the quarter ended 2022-12-31, filed 2023-02-10, with 19 holding rows worth $306,916,946.
- Accession
- 0000950123-23-001542
- Filer
- CIK 1397144
- Filed
- 2023-02-10
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2022
A holdings report, 19 entries on the cover page, a total value of $306,916,946 stated on the cover page (in dollars after the unit check, H1), rows summing to $306,916,946 with VALUE read as dollars as filed, 13F file number 028-14285. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerCarlyle Group Inc. 028-15025
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| VAXCYTE INC COM | 92243G108 | Stock | 2,019,057 | $96,813,783 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 2,457,500 | $64,214,475 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 2,960,231 | $57,280,470 | dollars as filed | |
| HILLEVAX INC | 43157M102 | COM | 1,838,486 | $30,757,871 | dollars as filed | |
| ADICET BIO INC | 007002108 | COM | 2,115,385 | $18,911,542 | dollars as filed | |
| PHATHOM PHARMACEUTICALS INC | 71722W107 | COMMON STOCK | 1,435,106 | $16,101,889 | dollars as filed | |
| RENEO PHARMACEUTICALS INC | 75974E103 | COM | 2,073,957 | $4,832,320 | dollars as filed | |
| SIENTRA INC | 82621J105 | COM | 1,673,589 | $3,397,386 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871103 | COM | 5,628,558 | $2,718,594 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 1,201,506 | $2,378,982 | dollars as filed | |
| NUCANA PLC | 67022C106 | ADR | 3,333,333 | $2,200,000 | dollars as filed | |
| EFFECTOR THERAPEUTICS INC | 28202V108 | COM | 4,822,114 | $2,063,865 | dollars as filed | |
| SPRUCE BIOSCIENCES INC | 85209E109 | COM | 1,792,518 | $1,966,392 | dollars as filed | |
| PARATEK PHARMACEUTICALS INC | 699374302 | Equity | 1,041,131 | $1,946,915 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 131,036 | $821,596 | dollars as filed | |
| EXICURE INC | 30205M200 | COM NEW | 281,636 | $323,881 | dollars as filed | |
| AEGLEA BIOTHERAPEUTICS INC | 00773J103 | COM | 240,500 | $108,225 | dollars as filed | |
| MOLECULAR TEMPLATES INC | 608550109 | COM | 200,000 | $66,000 | dollars as filed | |
| ObsEva SA | H5861P103 | COM | 87,999 | $12,760 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-23-001542 | this filing | 2023-02-10 | acceptance time not in the bulk data set |